Market Updates - Angel One

In a recent trend, foreign portfolio investors are investing in the emerging economies rather than the developed economies and pumped in Rs 62,951 crores in November in the Indian market, the highest monthly FII inflow in 2020. National Securities Depository Limited (NSDL) published a report that marked foreign portfolio investors as the principal investor category …

SEBI has decided that it will relax some of the restrictions it had imposed to curb market volatility that ensued with the outbreak of COVID in India in March.  India’s COVID-19 cases started to climb in March, caused the government to place nationwide lockdown with hope to break the chain. It spiked widespread market speculation …

Since the outbreak of the global COVID-19 pandemic, the stock market outlook remained reserved. So, it is no wonder that the news of vaccine will give market the boost it has been looking for. NSE benchmark, Nifty50 on Tuesday, has set a record by climbing the 13,000 marks amid extensive buying in different categories by …

The market regulator has agreed to relax the current promoter re-classification norms to change status from promoters to general shareholders. After receiving several requests from different parties, the market watchdog decided to alter the current eligibility threshold from 10 to 15 percent. In a public consulting paper issued, SEBI proposed re-classification of promoters’ resolution and …

The Future-Reliance deal came under a shroud of doubts after Amazon’s insider trade allegation on Future Group.  In a letter written to the Indian market regulator SEBI, Amazon urged the market watchdog to probe insider trading possibilities in Reliance-Future Group deal. Amazon alleged that Future had disclosed price sensitive information to Reliance Retail regarding an …

The SENSEX seems to be on a festive mood over the new COVID-19 vaccine announcement. Both SENSEX and NIFTY clocked gains after American drug manufacturer Pfizer announced the much-awaited COVID-19 vaccine. The share price of the Indian arm of Pfizer gained 19.46 percent in SENSEX during intraday before closing at 2.66 percent in the green.  …

Biocon Chairperson and MD, Kiran Majumdar Shaw confirmed that she has IPO on her plate. And yes, she confirmed that Biocon is getting a USD 150 million investment from Goldman Sachs. Shaw confirmed that the pre-IPO investment is crucial for Biocon to reach the target of USD 1 billion in the next two years. Goldman …

The largest lender, SBI, has released its quarter2 performance report. It is creating quite a wave in the market since the banking sector is one of the worst-hit segments amid COVID-19 outbreak.  SBI Q2 results show 52 percent hike in net profit. Although the profit margin was less from quarter one that ended in June, …

Hyderabad based Gland Pharma will launch its IPO offer on November 9. The firm received SEBI approval last month but announced the IPO launch date recently. The firm was in talks with the merchant banks to set the price band for the scrips. The subscription window will remain open till November 11.  Gland Pharma is …

The festive season is upon us, and Diwali is just around the corner. As we worship the goddess of wealth, Laxmi, on the day of Diwali, it is considered auspicious to make financial transactions on that day. It is customary for the Indian bourses to organise special trading sessions on the day of Diwali, following …